Serum CA211 level and NK cell number are associated with prognosis of patients with non-small cell lung cancer

Serum CA211 level and NK cell number are associated with prognosis of patients with non-small cell lung cancer

Objective To exploring the correlation between the expression level of serum carbohydrate antigen 211 (CA211) and the number of natural killer (NK) cells and prognosis in non-small cell lung cancer (NSCLC) patients. Methods 132 NSCLC patients admitted to the Affiliated Hospital of Hangzhou Normal Un...

Full description

Bibliographic Details
Main Author:	DING Fei, WANG Sa, HUANG Changxin
Format:	Article
Language:	zho
Published:	Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College. 2024-02-01
Series:	Jichu yixue yu linchuang
Subjects:	non-small cell lung cancer\|carbohydrate antigen 211\|natural killer cell\|prognosis
Online Access:	http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/1001-6325-2024-44-2-180.pdf

Similar Items

Elevated Exhaustion Levels of NK and CD8+ T Cells as Indicators for Progression and Prognosis of COVID-19 Disease
by: Mingyue Li, et al.
Published: (2020-10-01)

Preclinical and clinical studies of CAR-NK-cell therapies for malignancies
by: Hongwen Li, et al.
Published: (2022-10-01)

The expression of miR-211-5p in atherosclerosis and its influence on diagnosis and prognosis
by: Yanxia Zhang, et al.
Published: (2021-08-01)

Molecular basis of NK cell recognition and function /
by: Moretta, Lorenzo
Published: (1996)

Research Progress of Chimeric Antigen Receptor NK Cells in Treatment of Lymphoma
by: HU Run, et al.
Published: (2023-12-01)

Porcine NK Cells Stimulate Proliferation of Pseudorabies Virus-Experienced CD8+ and CD4+CD8+ T Cells
by: Steffi De Pelsmaeker, et al.
Published: (2019-01-01)

NK Cells Equipped With a Chimeric Antigen Receptor That Overcomes Inhibition by HLA Class I for Adoptive Transfer of CAR-NK Cells
by: Xiaoxuan Zhuang, et al.
Published: (2022-05-01)

You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy
by: Aline Pfefferle, et al.
Published: (2020-03-01)

From CAR-T Cells to CAR-NK Cells: A Developing Immunotherapy Method for Hematological Malignancies
by: Hui Lu, et al.
Published: (2021-08-01)

IPSC-derived CAR-NK cells for cancer immunotherapy
by: Xiaotong Lin, et al.
Published: (2023-09-01)

NK Cell-Based Immunotherapy and Therapeutic Perspective in Gliomas
by: Changqing Pan, et al.
Published: (2021-10-01)

Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond
by: Eunju Shin, et al.
Published: (2023-07-01)

CAR-NK cells in combination therapy against cancer: A potential paradigm
by: Junping Li, et al.
Published: (2024-03-01)

NK Cells Armed with Chimeric Antigen Receptors (CAR): Roadblocks to Successful Development
by: Ali Bashiri Dezfouli, et al.
Published: (2021-12-01)

Unconventional Peptide Presentation by Classical MHC Class I and Implications for T and NK Cell Activation
by: Dirk M. Zajonc
Published: (2020-10-01)

Donor selection for adoptive immunotherapy with NK cells in AML patients: Comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK cell repertoire
by: Raffaella Meazza, et al.
Published: (2023-02-01)

RETRACTED: CAR-NK Cell: A New Paradigm in Tumor Immunotherapy
by: Faroogh Marofi, et al.
Published: (2021-06-01)

Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential
by: Xiao Wang, et al.
Published: (2022-11-01)

microRNA-211 regulates cell proliferation, apoptosis and migration/invasion in human osteosarcoma via targeting EZRIN
by: Yihua Pei, et al.
Published: (2019-07-01)

Prospects for NK Cell Therapy of Sarcoma
by: Mieszko Lachota, et al.
Published: (2020-12-01)

CAR-NK Cells in the Treatment of Solid Tumors
by: Ewa Wrona, et al.
Published: (2021-05-01)

Prognosis and therapeutic benefits prediction based on NK cell marker genes through single-cell RNA-seq with integrated bulk RNA-seq analysis for hepatocellular carcinoma
by: Yao Yang, et al.
Published: (2023-07-01)

Challenges and Prospects for Designer T and NK Cells in Glioblastoma Immunotherapy
by: Victoria Smith Arnesen, et al.
Published: (2021-10-01)

Natural Killer (NK) Cell Education Differentially Influences HIV Antibody-Dependent NK Cell Activation and Antibody-Dependent Cellular Cytotoxicity
by: Nicole F. Bernard, et al.
Published: (2017-08-01)

Combination of Expanded Allogeneic NK Cells and T Cell-Based Immunotherapy Exert Enhanced Antitumor Effects
by: Xiao Wang, et al.
Published: (2022-12-01)

CAR NK92 Cells Targeting BCMA Can Effectively Kill Multiple Myeloma Cells Both In Vitro and In Vivo
by: Eunhee Park, et al.
Published: (2024-01-01)

Polyclonal Expansion of NKG2C+ NK Cells in TAP-deficient Patients
by: vivien eBeziat, et al.
Published: (2015-10-01)

Engineering NK Cells for CAR Therapy—Recent Advances in Gene Transfer Methodology
by: Paula Schmidt, et al.
Published: (2021-01-01)

Panoramic comparison between NK cells in healthy and cancerous liver through single-cell RNA sequencing
by: Huan Liu, et al.
Published: (2022-09-01)

Assessment of T Cell Receptor Complex Expression Kinetics in Natural Killer Cells
by: Khder H. Rasul, et al.
Published: (2022-08-01)

The Novel-Natural-Killer-Cell-Related Gene Signature Predicts the Prognosis and Immune Status of Patients with Hepatocellular Carcinoma
by: Minjun Li, et al.
Published: (2023-05-01)

Enhanced CT-based radiomics model to predict natural killer cell infiltration and clinical prognosis in non-small cell lung cancer
by: Xiangzhi Meng, et al.
Published: (2024-01-01)

In-depth analysis of prognostic markers associated with the tumor immune microenvironment and genetic mutations in breast cancer based on an NK cell-related risk model
by: Dongmin Yu, et al.
Published: (2024-01-01)

Symptomatic Carotid Atherosclerotic Plaques Are Associated With Increased Infiltration of Natural Killer (NK) Cells and Higher Serum Levels of NK Activating Receptor Ligands
by: Irene Bonaccorsi, et al.
Published: (2019-07-01)

TXNIP Promotes Human NK Cell Development but Is Dispensable for NK Cell Functionality
by: Eva Persyn, et al.
Published: (2022-09-01)

The role of NK and NKT cells in the pathogenesis and improvement of multiple sclerosis following disease‐modifying therapies
by: Alireza Ahmadi, et al.
Published: (2022-01-01)

Study of <sup>211</sup>Bi and <sup>211</sup>Pb Recoils Release from <sup>223</sup>Ra Labelled TiO<sub>2</sub> Nanoparticles
by: Ján Kozempel, et al.
Published: (2022-12-01)

Engineered NK Cells Against Cancer and Their Potential Applications Beyond
by: Maria Karvouni, et al.
Published: (2022-02-01)

MicroRNA-211 Promotes Non-Small-Cell Lung Cancer Proliferation and Invasion by Targeting MxA [Retraction]
by: Kang M, et al.
Published: (2022-11-01)

Effect of Anger Patterns and Depression on Serum IgA and NK Cell Frequency
by: Alireza Farnam, et al.
Published: (2016-03-01)